Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAMS | ELVN | BCRX | ||
| Company | Newamsterdam Pharma Company N.V. | Enliven Therapeutics Inc | Biocryst Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.93 | 58.71 | 9.72 | ||
| High | 27.39 | 59.65 | 10.02 | ||
| Low | 26.51 | 57.92 | 9.65 | ||
| Last | 26.90 | 59.53 | 9.94 | ||
| Change | -0.08 | +0.72 | +0.20 | ||
| Percent Change | -0.30% | +1.22% | +2.05% | ||
| Volume | 834,900 | 529,300 | 2,122,200 | ||
| 20-Day Average Volume | 1,146,620 | 1,012,975 | 3,351,835 | ||
| Previous | 26.98 | 58.82 | 9.74 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.43 | 56.66 | 9.53 | ||
| 20-Day Raw Stochastic | 16.85% | 74.04% | 61.46% | ||
| 20-Day Relative Strength | 38.38 | 64.12 | 54.06 | ||
| Weighted Alpha | -20.40 | +93.63 | +25.08 | ||
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 48% Sell | 100% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.86% since 08/10/26 | +0.19% since 08/10/26 | +1.02% since 08/10/26 | ||
| Low | 26.01 on 08/14/26 | 56.69 on 08/14/26 | 9.46 on 08/14/26 | ||
| High | 28.63 on 08/11/26 | 60.38 on 08/12/26 | 10.68 on 08/12/26 | ||
| 1-Month | |||||
| %Chg | -15.09% since 07/17/26 | +11.91% since 07/17/26 | +7.00% since 07/17/26 | ||
| Low | 25.74 on 08/05/26 | 51.39 on 07/20/26 | 8.76 on 08/04/26 | ||
| High | 32.63 on 07/22/26 | 62.32 on 08/05/26 | 10.68 on 08/12/26 | ||
| 3-Month | |||||
| %Chg | -24.10% since 05/15/26 | +44.01% since 05/15/26 | +10.20% since 05/15/26 | ||
| Low | 25.74 on 08/05/26 | 33.45 on 06/08/26 | 8.06 on 06/03/26 | ||
| High | 37.37 on 07/07/26 | 62.32 on 08/05/26 | 11.22 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | -23.67% since 02/17/26 | +127.84% since 02/17/26 | +43.02% since 02/17/26 | ||
| Low | 25.74 on 08/05/26 | 25.29 on 02/20/26 | 6.97 on 02/18/26 | ||
| High | 42.21 on 05/11/26 | 62.32 on 08/05/26 | 11.22 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,225,108 | 4,309,801 | 2,488,911 | ||
| Shares Outstanding, K | 119,537 | 73,271 | 255,535 | ||
| Annual Sales, $M | 22,500,000 | 0 | 874,840,000 | ||
| Annual Net Income, $M | -203,820,000 | -103,690,000 | 263,860,000 | ||
| Last Qtr Sales, $M | 3,700,000 | 0 | 218,250,000 | ||
| Last Qtr Income, $M | -64,140,000 | -32,490,000 | 78,400,000 | ||
| 60-Month Beta | 0.10 | 0.27 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 08/05/26 | -0.49 on 08/05/26 | 0.30 on 08/05/26 | ||
| Latest Earnings Date | 11/04/26 | 11/11/26 | 11/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.77 | ||